Clinical Trial Update: Investigating the Effects of QVM149 on MRI Ventilation Defects [Phase 3]

View source ↗

Summary

Phase 3 trial investigating QVM149 for asthma with status listed as withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• QVM149 (Indacaterol acetate / glycopyrronium bromide / mometasone furoate)

Snippet

Sponsor: Dr. Grace Parraga | Conditions: Asthma | Phase 3 | Status: WITHDRAWN